Skip to main content

A digital app for schizophrenia and psychosis

Amos Adler, founder and president of MEMOTEXT, discusses how the company builds and commercializes digital engagement tools, its digital app for schizophrenia and psychosis patients, and Canadian vs. U.S. markets for digital therapeutics.
By HIMSS TV